JP2023537625A5 - - Google Patents

Info

Publication number
JP2023537625A5
JP2023537625A5 JP2023511556A JP2023511556A JP2023537625A5 JP 2023537625 A5 JP2023537625 A5 JP 2023537625A5 JP 2023511556 A JP2023511556 A JP 2023511556A JP 2023511556 A JP2023511556 A JP 2023511556A JP 2023537625 A5 JP2023537625 A5 JP 2023537625A5
Authority
JP
Japan
Prior art keywords
seq
aav
acid sequence
amino acid
encoding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023511556A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023537625A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/045945 external-priority patent/WO2022036220A1/en
Publication of JP2023537625A publication Critical patent/JP2023537625A/ja
Publication of JP2023537625A5 publication Critical patent/JP2023537625A5/ja
Pending legal-status Critical Current

Links

JP2023511556A 2020-08-14 2021-08-13 新規aavカプシド及びそれを含む組成物 Pending JP2023537625A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063065616P 2020-08-14 2020-08-14
US63/065,616 2020-08-14
US202063109734P 2020-11-04 2020-11-04
US63/109,734 2020-11-04
PCT/US2021/045945 WO2022036220A1 (en) 2020-08-14 2021-08-13 Novel aav capsids and compositions containing same

Publications (2)

Publication Number Publication Date
JP2023537625A JP2023537625A (ja) 2023-09-04
JP2023537625A5 true JP2023537625A5 (cg-RX-API-DMAC7.html) 2024-08-13

Family

ID=77595666

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023511556A Pending JP2023537625A (ja) 2020-08-14 2021-08-13 新規aavカプシド及びそれを含む組成物

Country Status (11)

Country Link
US (1) US20230287451A1 (cg-RX-API-DMAC7.html)
EP (1) EP4196170A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023537625A (cg-RX-API-DMAC7.html)
KR (1) KR20230051208A (cg-RX-API-DMAC7.html)
CN (1) CN116209769A (cg-RX-API-DMAC7.html)
AU (1) AU2021325954A1 (cg-RX-API-DMAC7.html)
CA (1) CA3188956A1 (cg-RX-API-DMAC7.html)
IL (1) IL300410A (cg-RX-API-DMAC7.html)
MX (1) MX2023001863A (cg-RX-API-DMAC7.html)
TW (1) TW202221127A (cg-RX-API-DMAC7.html)
WO (1) WO2022036220A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022262771A1 (en) 2021-04-23 2023-11-02 The Trustees Of The University Of Pennsylvania Novel compositions with brain-specific targeting motifs and compositions containing same
US20250171515A1 (en) * 2022-03-03 2025-05-29 The Trustees Of The University Of Pennsylvania Aav vectors for delivery of glp-1 receptor agonist fusions
WO2024015966A2 (en) * 2022-07-15 2024-01-18 The Trustees Of The University Of Pennsylvania Recombinant aav having aav clade d and clade e capsids and compositions containing same
CN117801116A (zh) * 2022-09-30 2024-04-02 上海玮美基因科技有限责任公司 一种融合型新型腺相关病毒及其应用
EP4634394A2 (en) 2022-12-17 2025-10-22 The Trustees of The University of Pennsylvania Recombinant aav mutant vectors with cardiac and skeletal muscle-specific targeting motifs and compositions containing same
WO2024130070A2 (en) 2022-12-17 2024-06-20 The Trustees Of The University Of Pennsylvania Recombinant aav capsids with cardiac- and skeletal muscle- specific targeting motifs and uses thereof
JP2026522354A (ja) 2023-06-12 2026-07-07 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア ムコ多糖症iiibのためのaav遺伝子療法
WO2025007046A1 (en) 2023-06-29 2025-01-02 The Trustees Of The University Of Pennsylvania Mutant aav with central nervous system targeting motifs and compositions containing same
WO2025039622A1 (zh) * 2023-08-23 2025-02-27 上海金珂博生物技术有限公司 经修饰的腺相关病毒载体及其在治疗中枢神经系统疾病中的用途
KR20260114566A (ko) 2023-11-14 2026-07-22 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 심근 및 골격근-특이적 표적화 모티프를 갖는 조성물 및 이의 용도
WO2025157137A1 (zh) * 2024-01-25 2025-07-31 鼐济医药科技(杭州)有限公司 Aav载体、载体组合物、嵌合载体和治疗或预防sma的方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174666B1 (en) 1992-03-27 2001-01-16 The United States Of America As Represented By The Department Of Health And Human Services Method of eliminating inhibitory/instability regions from mRNA
US5478745A (en) 1992-12-04 1995-12-26 University Of Pittsburgh Recombinant viral vector system
US6200560B1 (en) 1998-10-20 2001-03-13 Avigen, Inc. Adeno-associated virus vectors for expression of factor VIII by target cells
US6221349B1 (en) 1998-10-20 2001-04-24 Avigen, Inc. Adeno-associated vectors for expression of factor VIII by target cells
CN103589692B (zh) 2001-11-13 2018-07-24 宾夕法尼亚大学托管会 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法
DK2359869T3 (en) 2001-12-17 2019-04-15 Univ Pennsylvania Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof
EP1486567A1 (en) 2003-06-11 2004-12-15 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Improved adeno-associated virus (AAV) vector for gene therapy
US8005620B2 (en) 2003-08-01 2011-08-23 Dna Twopointo Inc. Systems and methods for biopolymer engineering
WO2005012877A2 (en) 2003-08-01 2005-02-10 Dna Twopointo Inc. Systems and methods for antibody engineering
EP2287323A1 (en) 2009-07-31 2011-02-23 Association Institut de Myologie Widespread gene delivery to the retina using systemic administration of AAV vectors
WO2011126808A2 (en) 2010-03-29 2011-10-13 The Trustees Of The University Of Pennsylvania Pharmacologically induced transgene ablation system
FR2977562B1 (fr) 2011-07-06 2016-12-23 Gaztransport Et Technigaz Cuve etanche et thermiquement isolante integree dans une structure porteuse
WO2013155222A2 (en) 2012-04-10 2013-10-17 The Regents Of The University Of California Brain-specific enhancers for cell-based therapy
US9719106B2 (en) 2013-04-29 2017-08-01 The Trustees Of The University Of Pennsylvania Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereof
EP3564379A1 (en) * 2013-09-13 2019-11-06 California Institute of Technology Selective recovery
US11555059B2 (en) 2014-04-25 2023-01-17 The Trustees Of The University Of Pennsylvania LDLR variants and their use in compositions for reducing cholesterol levels
US10577627B2 (en) * 2014-06-09 2020-03-03 Voyager Therapeutics, Inc. Chimeric capsids
EP3632923A1 (en) * 2015-01-16 2020-04-08 Voyager Therapeutics, Inc. Central nervous system targeting polynucleotides
AU2016343979A1 (en) * 2015-10-29 2018-05-10 Voyager Therapeutics, Inc. Delivery of central nervous system targeting polynucleotides
IL278598B2 (en) * 2018-05-11 2025-11-01 Massachusetts Eye & Ear Infirmary Altering tissue tropism of adeno-associated viruses
WO2020223232A1 (en) * 2019-04-29 2020-11-05 The Trustees Of The University Of Pennsylvania Novel aav capsids and compositions containing same
IL298138A (en) * 2020-05-12 2023-01-01 Univ Pennsylvania Compositions for drg-specific reduction of transgene expression

Similar Documents

Publication Publication Date Title
JP2022530633A5 (cg-RX-API-DMAC7.html)
JP2022530544A5 (cg-RX-API-DMAC7.html)
JP2022530656A5 (cg-RX-API-DMAC7.html)
Grieger et al. Adeno-associated virus vectorology, manufacturing, and clinical applications
JP6619454B2 (ja) キャプシド
Li et al. Adeno-associated virus vectors: potential applications for cancer gene therapy
JP2022508182A5 (cg-RX-API-DMAC7.html)
Xu et al. Designing and optimizing AAV-mediated gene therapy for neurodegenerative diseases: from bench to bedside
JP2024514956A (ja) 組織標的化された改変aavカプシドおよびその使用方法
JP2018108113A5 (cg-RX-API-DMAC7.html)
JP2018522529A5 (cg-RX-API-DMAC7.html)
JP2022531861A5 (cg-RX-API-DMAC7.html)
JP2020533959A5 (cg-RX-API-DMAC7.html)
TW201629225A (zh) 第九因子基因療法
JP2024161365A (ja) Aavキャプシドの転写依存性定方向進化を使用するための方法
US20040087028A1 (en) Ecdysone-inducible adeno-associated virus expression vectors
JP2022547197A5 (cg-RX-API-DMAC7.html)
JP2017529395A5 (cg-RX-API-DMAC7.html)
JP2022545121A (ja) Aav5の単離修飾vp1カプシドタンパク質
US20240269161A1 (en) Methods and compositions for tau reduction gene therapy
JP2023537980A5 (cg-RX-API-DMAC7.html)
JP2023550581A5 (cg-RX-API-DMAC7.html)
JP2021520811A5 (cg-RX-API-DMAC7.html)
Ortolano et al. Present and future of adeno associated virus based gene therapy approaches
JP2024515626A5 (cg-RX-API-DMAC7.html)